Rapid Discrimination of Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis Using Machine Learning on Infrared Spectra of Sera
Authors:
- Youssef El KhouryYKYoussef El Khoury
- Marie GebelinMGMarie Gebelin
- Jérôme de SèzeJSJérôme de Sèze
- Christine Patte-MensahCPChristine Patte-Mensah
- Gilles MarcouGMGilles Marcou
- Alexandre VarnekAlexandre Varnek
- Ayikoé-Guy Mensah-NyaganAMAyikoé-Guy Mensah-Nyagan
- Petra HellwigPetra Hellwig
- Nicolas CollonguesNCNicolas Collongues
Open Access
- 3 March 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (5) , 2791
Abstract
Neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) are both autoimmune inflammatory and demyelinating diseases of the central nervous system. NMOSD is a highly disabling disease and rapid introduction of the appropriate treatment at the acute phase is crucial to prevent sequelae. Specific criteria were established in 2015 and provide keys to distinguish NMOSD and MS. One of the most reliable criteria for NMOSD diagnosis is detection in patient’s serum of an antibody that attacks the water channel aquaporin-4 (AQP-4). Another target in NMOSD is myelin oligodendrocyte glycoprotein (MOG), delineating a new spectrum of diseases called MOG-associated diseases. Lastly, patients with NMOSD can be negative for both AQP-4 and MOG antibodies. At disease onset, NMOSD symptoms are very similar to MS symptoms from a clinical and radiological perspective. Thus, at first episode, given the urgency of starting the anti-inflammatory treatment, there is an unmet need to differentiate NMOSD subtypes from MS. Here, we used Fourier transform infrared spectroscopy in combination with a machine learning algorithm with the aim of distinguishing the infrared signatures of sera of a first episode of NMOSD from those of a first episode of relapsing-remitting MS, as well as from those of healthy subjects and patients with chronic inflammatory demyelinating polyneuropathy. Our results showed that NMOSD patients were distinguished from MS patients and healthy subjects with a sensitivity of 100% and a specificity of 100%. We also discuss the distinction between the different NMOSD serostatuses. The coupling of infrared spectroscopy of sera to machine learning is a promising cost-effective, rapid and reliable differential diagnosis tool capable of helping to gain valuable time in patients’ treatment.Keywords
This publication has 33 references indexed in Scilit:
- Attenuated Total Reflection Fourier Transform Infrared (ATR‐FTIR) spectral discrimination of brain tumour severity from serum samplesJournal of Biophotonics, 2014
- Aquaporin-4 antibody–negative neuromyelitis opticaNeurology, 2013
- A Benign Form of Neuromyelitis OpticaArchives of Neurology, 2011
- Neuromyelitis optica in FranceNeurology, 2010
- Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system diseaseAnnals of Neurology, 2009
- Infrared spectroscopy of proteinsBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2007
- Immunosuppressive therapy is more effective than interferon in neuromyelitis opticaMultiple Sclerosis Journal, 2007
- Revised diagnostic criteria for neuromyelitis opticaNeurology, 2006
- Using two discrete frequencies within the middle infrared to quantitatively determine glucose in serumJournal of Biomedical Optics, 2002
- Interpretation of dna vibrational spectra by normal coordinate analysisInternational Journal of Biochemistry, 1990